Combinatorial enzyme design probes allostery and cooperativity in the trypsin fold.
Converting one enzyme into another is challenging due to the uneven distribution of important amino acids for function in both protein sequence and structure. We report a strategy for protein engineering allowing an organized mixing and matching of genetic material that leverages lower throughput with increased quality of screens. Our approach successfully tested the contribution of each surface-exposed loop in the trypsin fold alone and the cooperativity of their combinations towards building the substrate selectivity and Na(+)-dependent allosteric activation of the protease domain of human coagulation factor Xa into a bacterial trypsin. As the created proteases lack additional protein domains and protein co-factor activation mechanism requisite for the complexity of blood coagulation, they are stepping-stones towards further understanding and engineering of artificial clotting factors.
Page
Michael J
MJ
Department of Pharmaceutical Chemistry, University of California San Francisco, San Francisco, CA, USA.
Di Cera
Enrico
E
D001426:Bacterial Proteins / Q000737:chemistry / Q000235:genetics; D019020:Directed Molecular Evolution; D015951:Factor Xa / Q000737:chemistry* / Q000235:genetics*; D006801:Humans; D015202:Protein Engineering / Q000379:methods*; D014357:Trypsin / Q000737:chemistry* / Q000235:genetics*
D001426:Bacterial Proteins; D014357:Trypsin; D015951:Factor Xa
Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3
15299374
J Mol Biol. 1993 Aug 5;232(3):947-66
8355279
J Thromb Haemost. 2007 Jul;5 Suppl 1:81-94
17635714
J Biol Chem. 2008 Oct 31;283(44):30010-4
18768474
Science. 1992 Mar 6;255(5049):1249-53
1546324
J Biol Chem. 2000 Nov 24;275(47):36876-84
10973949
Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9813-8
9707558
J Biol Chem. 2001 Jul 6;276(27):25143-9
11312264
Biochemistry. 2000 Feb 22;39(7):1817-25
10677232
Curr Opin Chem Biol. 2006 Oct;10(5):498-508
16939713
Cancer Metastasis Rev. 2003 Jun-Sep;22(2-3):237-58
12784999
Trends Mol Med. 2009 Jul;15(7):303-12
19581128
J Mol Biol. 2003 Jan 31;325(5):963-77
12527302
J Biol Chem. 2004 Jan 30;279(5):3671-9
14583605
Nat Rev Microbiol. 2004 Mar;2(3):241-9
15083159
J Mol Biol. 2001 Jun 8;309(3):793-806
11397097
Biochemistry. 2003 Aug 5;42(30):9060-6
12885239
Chem Rev. 2002 Dec;102(12):4501-24
12475199
J Biol Chem. 2004 Nov 12;279(46):48262-9
15347660
J Biol Chem. 2004 Jul 23;279(30):31842-53
15152000
J Mol Biol. 2008 May 2;378(3):666-72
18377928
Physiol Rev. 2006 Oct;86(4):1049-92
17015484
Biochem Soc Trans. 2005 Apr;33(Pt 2):331-4
15787599
Trends Biochem Sci. 2009 Sep;34(9):453-63
19726197
J Biol Chem. 2004 Dec 24;279(52):54927-36
15494418
Chest. 2003 Sep;124(3 Suppl):4S-10S
12970118
Methods Enzymol. 1997;276:307-26
27754618
J Mol Biol. 2004 Jan 30;335(5):1325-41
14729347
J Biol Chem. 2002 Jun 7;277(23):20527-34
11925440
Cell Mol Life Sci. 2008 Apr;65(7-8):1220-36
18259688
Protein Sci. 1992 Apr;1(4):426-71
1304349
Protein Eng. 1998 Aug;11(8):669-73
9749919
Science. 1999 Oct 8;286(5438):295-9
10514373
J Mol Biol. 1988 Apr 5;200(3):523-51
3135412
J Thromb Haemost. 2005 Nov;3(11):2401-8
16241939
J Biol Chem. 1995 Jul 14;270(28):16854-63
7622501
Proc Natl Acad Sci U S A. 1958 Oct 15;44(10):1072-8
16590310
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
15572765
FEBS Lett. 1996 Jan 29;379(2):139-42
8635579
Anal Biochem. 2008 May 1;376(1):94-102
18261455
J Mol Biol. 2003 Jul 18;330(4):761-70
12850145
EMBO J. 2001 Jun 15;20(12):3036-45
11406580
Biochemistry. 2006 Mar 7;45(9):2987-93
16503653
Nat Rev Mol Cell Biol. 2002 Jul;3(7):509-19
12094217
Angew Chem Int Ed Engl. 2005 Jul 11;44(28):4400-4
15952226